Effects of oral paricalcitol therapy on arterial stiffness and osteopontin in hypertensive patients with chronic kidney disease and secondary hyperparathyroidism.

Michalis Giakoumis,Costas Tsioufis,Kyriakos Dimitriadis, Makro Sonikian,Alexandros Kasiakogias,Eirini Andrikou,Theodoros Kalos,Dimitrios Konstantinidis,Konstantinos Filis,Dimitrios Petras,Dimitrios Tousoulis

Hellenic Journal of Cardiology（2019）

引用 13|浏览17

暂无评分

摘要

Treatment with oral paricalcitol in hypertensive subjects suffering from CKD stages 3-5 and secondary hyperparathyroidism is accompanied by amelioration of arterial stiffness as reflected by the reduction of carotid-femoral PWV.

查看译文

关键词

Chronic kidney disease,Paricalcitol,Arterial stiffness,Hypertension,Osteopontin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要